- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Sep 25, 2020
Highlights
- Market Cap
- $11.73M
- Enterprise Value
- $3.56M
- EPS (TTM)
- -$0.01
- Gross Profit (TTM)
- -$5.00K
- EBITDA (TTM)
- -$23.09M
- Year Range
- $0.46 - $7.20
- Target Price
- $266.00
- ROA (TTM)
- -227.02%
- ROE (TTM)
- 1,770.29%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
CALC Performance Chart
CalciMedica Inc. Common Stock (CALC) is down 88.2% since the beginning of the year. At $1 per share, CALC is trading 89.2% below its 52-week high of $7. Investors who bought $1,000 worth of CALC shares 5 years ago would now be looking at an investment worth $11.
Loading charts...
Returns By Period
CalciMedica Inc. Common Stock (CALC) has returned -88.15% so far this year and -52.37% over the past 12 months.
CalciMedica Inc. Common Stock
- 1D
- 3.40%
- 1M
- 24.20%
- YTD
- -88.15%
- 6M
- -87.46%
- 1Y
- -52.37%
- 3Y*
- -38.20%
- 5Y*
- -59.45%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
CALC Monthly Returns History
Based on dividend-adjusted daily data since Sep 25, 2020, CALC's average daily return is -0.13%, while the average monthly return is -1.29%.
Historically, 36% of months were positive and 64% were negative. The best month was Jan 2024 with a return of +160.1%, while the worst month was Jan 2026 at -86.3%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 9 months.
On a daily basis, CALC closed higher 44% of trading days. The best single day was Apr 14, 2023 with a return of +58.6%, while the worst single day was Jan 28, 2026 at -75.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -86.34% | -42.63% | 4.59% | 9.26% | 38.47% | -4.39% | -88.15% | ||||||
| 2025 | -27.68% | -13.28% | -13.96% | -17.80% | 8.92% | -6.43% | 115.00% | -21.51% | 13.92% | -3.76% | 44.26% | 54.33% | 86.16% |
| 2024 | 160.14% | -41.13% | -5.02% | 37.74% | -0.87% | -30.28% | 17.93% | -10.71% | 6.24% | -16.48% | -6.76% | 2.61% | 23.78% |
| 2023 | 36.76% | -19.57% | -35.06% | -22.60% | 5.94% | -2.20% | -12.72% | -12.85% | -12.81% | -17.28% | 88.64% | -31.08% | -59.14% |
| 2022 | -26.23% | -1.48% | -7.52% | -13.01% | -8.83% | 11.74% | -11.93% | 4.17% | -5.96% | 9.53% | -39.92% | -19.20% | -72.68% |
| 2021 | 5.62% | -34.49% | -72.36% | -14.59% | -16.03% | 36.43% | -23.39% | 5.29% | -24.20% | -8.43% | -15.79% | -28.52% | -93.69% |
Benchmark Metrics
CalciMedica Inc. Common Stock has an annualized alpha of -33.49%, beta of 0.43, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since September 25, 2020.
- This stock participated in 176.99% of S&P 500 Index downside but only -106.58% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.43 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -33.49%
- Beta
- 0.43
- R²
- 0.00
- Upside Capture
- -106.58%
- Downside Capture
- 176.99%
Return for Risk
Risk / Return Rank
CALC ranks 33 for risk / return — below 33% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for CalciMedica Inc. Common Stock (CALC) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CALC | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.41 | ||
| Sortino ratioReturn per unit of downside risk | -2.20 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 1.37 | -0.28 |
| Calmar ratioReturn relative to maximum drawdown | -0.57 | 2.78 | -3.35 |
| Martin ratioReturn relative to average drawdown | -0.89 | 12.44 | -13.33 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the CalciMedica Inc. Common Stock. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the CalciMedica Inc. Common Stock was 99.90%, occurring on Mar 2, 2026. The portfolio has not yet recovered.
The current CalciMedica Inc. Common Stock drawdown is 99.84%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -99.90%Mar 2026 | 5y 1mo | — | 5y 5moJan 2021 - now |
2020 bear market2020 | -45.15%Dec 2020 | 17d | 1mo 12d | 1mo 29dNov 2020 - Jan 2021 |
2020 bear market2020 | -33.11%Sep 2020 | 5d | 1mo 6d | 1mo 11dSep 2020 - Nov 2020 |
2020 correction2020 | -10.38%Nov 2020 | 0s | 5d | 5dNov 2020 - Nov 2020 |
2020 pullback2020 | -3.57%Nov 2020 | 1d | 4d | 5dNov 2020 - Nov 2020 |
Drawdown Indicators
| CALC | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.90% | -56.78% | -43.12% |
Max Drawdown (1Y)Largest decline over 1 year | -92.48% | -9.10% | -83.38% |
Max Drawdown (3Y)Largest decline over 3 years | -93.19% | -18.90% | -74.29% |
Max Drawdown (5Y)Largest decline over 5 years | -99.41% | -25.43% | -73.98% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -99.84% | -1.80% | -98.04% |
Average DrawdownAverage peak-to-trough decline | -91.20% | -10.71% | -80.49% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 58.99% | 2.03% | +56.96% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of CalciMedica Inc. Common Stock over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how CalciMedica Inc. Common Stock is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with CALC
Add CalciMedica Inc. Common Stock to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with CALC